Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study
Jennifer K. King, Shiou‐Hwei Yeh, Ming‐Wei Lin, Chun‐Jen Liu, Ming‐Yang Lai, Jia‐Horng Kao, Ding‐Shinn Chen, Pei‐Jer Chen – 7 March 2007 – Interferon alfa (IEN‐α) therapy remains a mainstay of treatment in active hepatitis B. However, sustained remission rates remain relatively low, and the search for factors important for response to therapy continues. Our study aimed to identify the host single nucleotide polymorphisms (SNPs) that predict IFN response in hepatitis B patients.